Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivostat is a Danish medical technology company that specializes in the development of automated systems for the preparation and application of autologous fibrin sealant and Platelet Rich Fibrin (PRF). The company's core technology, the Vivostat System, allows healthcare professionals to process a patient's own blood at the point of care to create a biocompatible sealant or growth factor-rich solution. These products are utilized across a wide range of surgical specialties, including cardiothoracic, neurosurgery, and orthopedics, to promote hemostasis and tissue healing. Additionally, Vivostat has a strong presence in advanced wound care, providing solutions for hard-to-heal chronic wounds such as diabetic foot ulcers. By using autologous materials, the system eliminates the risk of viral transmission or allergic reactions associated with bovine or pooled human products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivostat International.